Tower Research Capital (TRC)’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Tower Research Capital (TRC)’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-447	Closed	-$4K	–	5090
2016 Q3	$4K	Buy	+447	New	+$3.18K	﹤0.01%	2798
2016 Q2	–	Sell	-257	Closed	-$1K	–	5602
2016 Q1	$1K	Sell	257 -706	-73%	-$2.84K	﹤0.01%	4002
2015 Q4	$5K	Buy	963 +263	+38%	+$1.53K	﹤0.01%	3131
2015 Q3	$4K	Sell	700 -7,253	-91%	-$88.9K	﹤0.01%	3076
2015 Q2	$126K	Sell	7,953 -19,525	-71%	-$237K	0.01%	636
2015 Q1	$299K	Buy	27,478 +27,084	+6,874%	+$276K	0.04%	258
2014 Q4	$4K	Buy	+394	New	+$3.85K	﹤0.01%	3043
2014 Q2	–	Sell	-5	Closed	–	–	5455
2014 Q1	$0	Sell	5 -1,753	-100%	-$25.3K	﹤0.01%	5598
2013 Q4	$23K	Sell	1,758 -510	-22%	-$7.02K	﹤0.01%	2198
2013 Q3	$34K	Buy	+2,268	New	+$27.2K	﹤0.01%	2266

Tower Research Capital (TRC)'s RPTP Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 447 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in RPTP in Q3 2013 and held it in 10 quarters. The position peaked at $299K in Q1 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Tower Research Capital (TRC) reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 447 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $4K.
Tower Research Capital (TRC) first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 10 quarters.
Tower Research Capital (TRC)'s RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $299K in Q1 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.